Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$12,688,192
+$1,231,689 QoQ
Shares Held
50,422
-4.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
#798
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealthcare Advisory Partners LLC holds $56,868,613 across 12 Drug Manufacturers - General names. ABBV ranks #1 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
50,422 | $12,688,192 | |
| 2 | LLY |
ELI LILLY & Co
|
10,304 | $12,358,927 | |
| 3 | JNJ |
Johnson & Johnson
|
37,978 | $9,645,272 | |
| 4 | AMGN |
Amgen Inc
|
15,360 | $5,562,163 | |
| 5 | MRK |
Merck & Co., Inc.
|
34,872 | $4,481,052 | |
| 6 | PFE |
Pfizer Inc
|
147,571 | $3,553,509 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
19,347 | $2,444,299 | |
| 8 | AZN |
Astrazeneca PLC
|
12,112 | $2,296,677 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,688,192 | 50,422 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $11,456,503 | 52,676 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $15,851,950 | 69,377 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $10,723,080 | 46,312 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $8,539,448 | 46,005 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $9,198,347 | 43,902 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $7,683,392 | 43,238 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $8,549,106 | 43,291 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $7,512,747 | 43,801 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,800,617 | 42,837 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $5,370,175 | 34,653 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,969,511 | 33,339 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $4,535,146 | 33,661 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $6,337,507 | 39,766 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $6,332,687 | 39,185 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,430,674 | 33,013 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,876,001 | 31,836 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,352,061 | 33,015 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $4,930,726 | 36,416 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,333,245 | 40,171 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,409,067 | 39,143 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,345,249 | 40,152 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $3,040,166 | 28,373 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,396,374 | 27,359 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $2,506,142 | 25,526 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $1,640,065 | 21,526 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||